ArticleArthritis research & therapy2018

Effects of selexipag and its active metabolite in contrasting the profibrotic myofibroblast activity in cultured scleroderma skin fibroblasts.

Maurizio Cutolo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.